Ikena Oncology, Inc.

Ikena Oncology, Inc. - Enterprise Valueverified

IKNA

Price:

$17.16

Market Cap:

$56.62M

Ikena Oncology, Inc. is a biopharmaceutical company specializing in precision oncology. Its primary objective is to create therapeutic agents specifically formulated for patient populations identified through biomarkers, thereby addressing significant unmet medical needs. The company's leading drug candidate is IK-930, an orally administered small molecule designed to inhibit the transcriptional enhanced associate domain (TEAD) transcription factor, a key component of the Hippo signaling pathway. Ikena is also progressing a portfolio of other investigational therapies, including: A small molecule inhibitor program targeting ERK5 within the RAS signaling pathway. IK-175, an oral compound that...[Read more]

Industry

Biotechnology

IPO Date

2021-03-26

Stock Exchange

NASDAQ

Ticker

IKNA

The Enterprise Value as of September 2026 (TTM) for Ikena Oncology, Inc. (IKNA) is -36143918.00

According to Ikena Oncology, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -36143918.00. This represents a change of -815.36% compared to the average of 5.05M of the last 4 quarters.

Ikena Oncology, Inc. (IKNA) Historical Enterprise Value (quarterly & annually)

How has IKNA Enterprise Value performed in the past?

The mean historical Enterprise Value of Ikena Oncology, Inc. over the last ten years is 435.86M. The current -36143918.00 Enterprise Value has changed -929.25% with respect to the historical average. Over the past ten years (40 quarters), IKNA's Enterprise Value was at its highest in in the December 2019 quarter at 1.14B. The Enterprise Value was at its lowest in in the September 2025 quarter at -22713734.85.

Quarterly (TTM)
Annual

Average

435.86M

Median

133.97M

Minimum

-26937900.28

Maximum

1.19B

Ikena Oncology, Inc. (IKNA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Ikena Oncology, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Enterprise Value = 1.19B

Minimum Annual Increase = -249.46%

Minimum Annual Enterprise Value = -26937900.28

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202512.51M-249.46%
2024-8370616.32-68.93%
2023-26937900.28-164.08%
202242.04M-81.39%
2021225.90M-77.06%
2020984.93M-7.53%
20191.07B-10.62%

Ikena Oncology, Inc. (IKNA) Average Enterprise Value

How has IKNA Enterprise Value performed in the past?

The current Enterprise Value of Ikena Oncology, Inc. (IKNA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-7599334.97

5-year avg

49.03M

10-year avg

435.86M

Ikena Oncology, Inc. (IKNA) Enterprise Value vs. Peers

How is IKNA’s Enterprise Value compared to its peers?

Ikena Oncology, Inc.’s Enterprise Value is less than ASLAN Pharmaceuticals Limited (782.70M), less than Exscientia plc (235.87M), less than Icosavax, Inc. (718.99M), less than Avid Bioservices, Inc. (968.63M), less than Chimerix, Inc. (770.49M), less than Sage Therapeutics, Inc. (488.88M), less than Intercept Pharmaceuticals, Inc. (1.08B), less than Invivyd, Inc. (68.15M), less than iTeos Therapeutics, Inc. (245.99M), less than Niagen Bioscience Inc (173.73M),

Build a custom stock screener for Ikena Oncology, Inc. (IKNA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ikena Oncology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ikena Oncology, Inc. (IKNA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ikena Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Ikena Oncology, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Ikena Oncology, Inc. (IKNA)?

What is the 3-year average Enterprise Value for Ikena Oncology, Inc. (IKNA)?

What is the 5-year average Enterprise Value for Ikena Oncology, Inc. (IKNA)?

How does the current Enterprise Value for Ikena Oncology, Inc. (IKNA) compare to its historical average?